Finance Ministry provides Rs 4500 Cr to boost vaccine production biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Apr 18, 2021, 15:27 IST
The number of coronavirus cases is soaring up in the country. Google Maps has now come up with a feature that would help people find COVID-19 vaccination centres.
If the users of Google Maps look for vaccination centres in the app, all centres in the area will be shown on their phones. The app will also include other details, such as whether the vaccination centre is open or not, in addition to the location of the vaccination centre.
In a blog post, Karen DeSalvo, Google s Chief Health Officer, stated that the company is funding vaccines for 2,50,000 people in countries that are in need. The vaccination centres can also be found on Google Maps and Search in the United States, Canada, France, Chile, India, and Singapore.
Updated Apr 16, 2021 | 06:15 IST
Accordingly, the chief minister has asked Kunte to appoint a senior officer to monitor and carry out the production in the given time-frame. Covaxin vaccine | Photo Credit: IANS
Mumbai: The Union government has given its permission to the Mumbai-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of Bharat Biotech, an official said on Thursday.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister s office (CMO) said.
Renu Swarup, secretary of the Union Science and Technology Department sent the approval letter to the Maharashtra chief secretary Sitaram Kunte, the official said.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister's office (CMO) said.
Representative Image
MUMBAI: Nearly a month after chief minister Uddhav Thackeray raised a demand with Prime Minister Narendra Modi to allow Maharashtra’s Haffkine Institute to manufacture Covaxin at its facility, the department of science and technology approved its technology transfer from the Hyderabad-based Bharat Biotech to Haffkine Bio-Pharmaceutical Corporation on Thursday.
Chief secretary Sitaram Kunte confirmed the approval and said this is the first such nod for any state and the Maharashtra government has budgeted Rs 150 crore for expansion of the plant at the Parel facility. The approval has come on the basis of recommendations by the technical committee and Haffkine has been given one year to roll out the vaccines.